The dual role of metabolic reprogramming in macrophage polarization in rheumatoid arthritis and coronary heart disease and the intervention strategy of traditional Chinese medicine - Report - MDSpire

The dual role of metabolic reprogramming in macrophage polarization in rheumatoid arthritis and coronary heart disease and the intervention strategy of traditional Chinese medicine

  • By

  • Haichun Zheng

  • Xiuyue Li

  • Jing Ru

  • Zhuoran Meng

  • Weibing Liu

  • Tao Jia

  • Shan Zhang

  • Qianwen Deng

  • Wenyi Huang

  • Renjie Dong

  • Qianrong Li

  • June 30, 2026

  • 0 min

Share

Metabolic Reprogramming's Dual Function in Macrophage Polarization

Overview

This review discusses the metabolic reprogramming of macrophages and its dual role in rheumatoid arthritis (RA) and coronary heart disease (CHD).

Background

Macrophage polarization is crucial in the pathogenesis of chronic inflammatory diseases like RA and CHD. The metabolic state of macrophages influences their inflammatory characteristics.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Pro-inflammatory M1 macrophages prefer aerobic glycolysis, while anti-inflammatory M2 macrophages rely on oxidative phosphorylation.
  • In RA and CHD, the balance of macrophage metabolism is disrupted towards glycolysis.
  • Metabolic regulators such as Pim2 kinase and phosphoglycerate kinase 1 are involved in macrophage metabolism in RA.
  • Activation of the PI3K/AKT pathway in CHD promotes glycolytic metabolism in macrophages.
  • Traditional Chinese medicine compounds like berberine and ginsenoside Rb1 are mentioned in the context of macrophage metabolism.

Clinical Implications

Understanding the metabolic pathways of macrophages in RA and CHD may inform future research directions.

Conclusion

Further exploration of macrophage metabolism in RA and CHD is warranted.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Metrnl and Macrophage Polarization: Role in Skeletal Muscle Homeostasis and Therapeutic Potential
  2. Frontiers in Immunology, 2026 -- Metabolic reprogramming of glutamine is associated with M2 macrophage polarization in allergic rhinitis
  3. Basic Research in Cardiology, 2023 -- Therapeutic Strategies Utilizing Macrophages for Treating Cardiovascular Disorders
  4. Frontiers in Immunology — Fatty Acid Metabolism and Lipid Channeling in Macrophages: Mechanisms of Inflammation, Resolution, and Lipotoxicity
  5. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
  6. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement
  7. ACC, AHA Issue New Acute Coronary Syndromes Guideline | American Heart Association
  8. 2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures | JACC
  9. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
  10. CANTOS
  11. Cardiovascular Inflammation Reduction Trial - American College of Cardiology
  12. Colchicine in Patients with Chronic Coronary Disease | New England Journal of Medicine
  13. Colchicine Cardiovascular Outcomes Trial - American College of Cardiology
  14. Colchicine in Acute Myocardial Infarction | New England Journal of Medicine
  15. Inflammation reprogramming and immunomodulation: Next-generation treatments for atherosclerosis
  16. Tongxinshu capsules in the treatment of stable angina pectoris due to qi deficiency and blood stasis in coronary heart disease: A multicenter, randomized, double-blind, placebo-controlled trial - ScienceDirect
  17. Efficacy and safety of Shexiang Baoxin Pill in patients with angina and non-obstructive coronary arteries: A multicenter, randomized, double-blind, placebo-controlled, phase Ⅳ clinical trial - PubMed
  18. Effects of Chinese Medicine on modulating interleukin-17-regulated macrophages in coronary heart disease - PubMed
  19. Curcumin for the clinical treatment of rheumatoid arthritis: a systematic review and meta-analysis of placebo-controlled randomized clinical trials - PMC
  20. Frontiers | Effects of plant active substances in rheumatoid arthritis—a systematic review and network meta-analysis
  21. Frontiers | Modulating M1/M2 macrophage polarization with plant metabolites: a therapeutic strategy for rheumatoid arthritis

Original Source(s)

Related Content